Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TLE family member 5, also known as TLE5 or Amino-terminal enhancer of split (AES), is a member of the Groucho/transducin-like enhancer of split (TLE) family of transcriptional corepressors[1][2][4]. Unlike the long TLE family members (TLE1–4), TLE5 is a short isoform lacking the WD repeat domain and functions primarily as a dominant negative regulator by binding to the Q domain of long TLE proteins and preventing tetramer formation, thus modulating their ability to repress target gene expression[1]. TLE5 also has independent roles: it participates in the negative regulation of NF-κB and androgen receptor target gene expression, modulates Wnt and Notch signaling pathways, and is essential for proper cell fate determination and differentiation. Loss of TLE5 function has been linked to enhanced tumor invasiveness and metastasis in several cancers and is associated with drug resistance[1][4]. No drugs are currently available that directly target TLE5, but inhibitors of related signaling pathways may modulate its activity or stability in disease contexts.
Dominant negative inhibition of long TLE members (suppresses TLE tetramer formation); corepression of gene expression via interaction with transcription factors (e.g., TCF/LEF1 in Wnt pathway, HES1 in Notch, and AR in androgen signaling); recruitment (or interference with recruitment) of HDACs for transcriptional suppression[1][2][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TLE family member 5, transcriptional modulator (TLE5).